Skip to content

Morphological analysis of circulating tumor cells in the diagnosis and treatment of lung cancer

Morphological analysis of circulating tumor cells in the diagnosis and treatment of lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035546
Enrollment
Unknown
Registered
2020-08-13
Start date
2019-10-30
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Gold Standard:Clinical outcome
Index test:CTCs morphology

Sponsors

Huadong Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with lung nodules undergoing surgical operations at the Department of Thoracic Surgery, Huadong Hospital, Fudan University from 2019 to 2020; 2. Preoperative chest CT examination of patients with suspected lung cancer; 3. The patient was pathologically diagnosed as lung cancer after surgery; 4. Patients who can obtain blood samples and tissue samples; 5. The sample is collected before the patient receives lung cancer related treatment.

Exclusion criteria

Exclusion criteria: Patients with a history of cancer, patients with other causes of lung resection, patients with atelectasis, pleural effusion, multiple nodules, and patients receiving radiotherapy and chemotherapy before surgery; patients with blood clot clotting or hemolysis;

Design outcomes

Primary

MeasureTime frame
tumor metastasis;ACC, SEN, SPE, AUC of ROC;

Countries

China

Contacts

Public ContactYun Wu

Huadong Hospital Affiliated to Fudan University

a.ore@live.cn+86 18917949428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026